Publications

An overview of the perspectives used in health economic evaluations.

Sittimart, M; Rattanavipapong, W; Mirelman, AJ; Hung, TM; Dabak, S; Downey, LE; JIT, M; Teerawattananon, Y; Turner, HC;

2024

Cost Effectiveness and Resource Allocation, (2024).22 1 10.1186/s12962-024-00552-1.

Estimating social contact rates for the COVID-19 pandemic using Google mobility and pre-pandemic contact surveys.

PRESTIGE, E; Coletti, P; Backer, J; Davies, N; Edmunds, J; Jarvis, C;

2023

medRxiv (2023). 10.1101/2023.12.19.23300209.

Phylogenetic inference of pneumococcal transmission from cross-sectional data, a pilot study.

Hackman, J; Sheppard, C; Phelan, J; JONES-WARNER, W; Sobkowiak, B; SHAH, S; Litt, D; Fry, NK; Toizumi, M; Yoshida, L-M; HIBBERD, M; MILLER, E; FLASCHE, S; Hué, S;

2023

Wellcome open research, (2023).8, 10.12688/wellcomeopenres.19219.1.

Comparison of collection methods for Phlebotomus argentipes sand flies to use in a molecular xenomonitoring system for the surveillance of visceral leishmaniasis.

McIntyre-Nolan, S; Kumar, V; Mark-Carew, M; Kumar, K; NIGHTINGALE, ES; Dalla Libera Marchiori, G; ROGERS, ME; KRISTAN, M; CAMPINO, S; MEDLEY, GF; Das, P; CAMERON, MM;

2023

PLoS neglected tropical diseases, (2023).17 9 10.1371/journal.pntd.0011200.

Evaluating the equity impact and cost-effectiveness of digital adherence technologies with differentiated care to support tuberculosis treatment adherence in Ethiopia: protocol and analysis plan for the health economics component of a cluster randomise...

FOSTER, N; TADESSE, AW; MCQUAID, CF; GOSCE, L; Abdurhman, T; Assefa, D; Bedru, A; HOUBEN, RM G J; Van Kalmthout, K; Letta, T; Mohammed, Z; Van Rest, J; Umeta, DG; Weldemichael, GT; Yazew, H; Jerene, D; Quaife, M; FIELDING, KL;

2023

Trials, (2023).24 1 10.1186/s13063-023-07289-x.

Gao, J; Fan, J; Zhou, H; JIT, M; Wang, P;

2023

BMJ paediatrics open, (2023).7 1 10.1136/bmjpo-2023-002031.

New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01 E and BCG-revaccination.

Clark, RA; Weerasuriya, CK; Portnoy, A; Mukandavire, C; Quaife, M; Bakker, R; SCARPONI, D; Harris, RC; Rade, K; Mattoo, SK; Tumu, D; Menzies, NA; WHITE, RG;

2023

medRxiv (2023). 10.1101/2023.02.24.23286406.

Tracking immune correlates of protection for emerging SARS-CoV-2 variants.

Nilles, EJ; Paulino, CT; De St Aubin, M; Duke, W; Jarolim, P; Sanchez, IM; Murray, KO; Lau, CL; Gutiérrez, EZ; Ramm, RS; Vasquez, M; KUCHARSKI, A;

2023

The Lancet. Infectious diseases, (2023).23 2 10.1016/s1473-3099(23)00001-4.

Outbreak risks, cases, and costs of vaccination strategies against wild poliomyelitis in polio-free settings: a modelling study.

AUZENBERGS, M; Abbas, K; Voorman, A; Peak, C; JIT, M; O'Reilly, K;

2023

medRxiv (2023). 10.1101/2023.07.05.23292288.

Genomic epidemiology of SARS-CoV-2 infections in The Gambia: an analysis of routinely collected surveillance data between March, 2020, and January, 2022.

KANTEH, A; Jallow, HS; Manneh, J; SANYANG, B; Kujabi, MA; Ndure, SL; JARJU, S; Sey, AP; Damilare K, D; Bah, Y; Sambou, S; Jarju, G; Manjang, B; Jagne, A; Bittaye, SO; Bittaye, M; FORREST, K; Tiruneh, DA; Samateh, AL; Jagne, S; Hué, S; MOHAMMED, N; AMAMBUA-NGWA, A; KAMPMANN, B; D'Alessandro, U; ... SESAY, AK.

2023

The Lancet Global health, (2023).11 3 10.1016/S2214-109X(22)00553-8.